F Ferrara

Summary

Country: Italy

Publications

  1. ncbi Therapeutic options and treatment results for patients over 75 years of age with acute myeloid leukemia
    F Ferrara
    Division of Hematology, Cardarelli Hospital, Naples, Italy
    Haematologica 83:126-31. 1998
  2. ncbi CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy
    F Ferrara
    Divisione di Ematologia, Sezione TERE, Servizio di Immunoematologia, Ospedale Cardarelli, Naples, Italy
    J Clin Oncol 18:1295-300. 2000
  3. ncbi Acute myeloid leukemia with t(8;21)/AML1/ETO: a distinct biological and clinical entity
    Felicetto Ferrara
    Divisione di Ematologia, Ospedale A Cardarelli, Naples, Italy
    Haematologica 87:306-19. 2002
  4. ncbi Therapy-related acute myeloid leukemia with t(9;11)(p12;q23) in a patient treated for acute promyelocytic leukemia
    Mario Annunziata
    Hematol J 4:289-91. 2003
  5. ncbi Vincristine as salvage treatment for refractory thrombotic thrombocytopenic purpura
    F Ferrara
    Division of Hematology, Cardarelli General Hospital, Naples, Italy
    Ann Hematol 78:521-3. 1999
  6. ncbi Complete remission in acute myeloid leukaemia with t(8;21) following treatment with G-CSF: flow cytometric analysis of in vivo and in vitro effects on cell maturation
    F Ferrara
    Division of Haematology, Cardarelli General Hospital, Napoli, Italy
    Br J Haematol 106:520-3. 1999
  7. ncbi Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of acute myeloid leukemia relapsing after autologous stem cell transplantation
    F Ferrara
    Divisione di Ematologia, Ospedale Cardarelli, Naples, Italy
    Ann Hematol 78:380-4. 1999
  8. ncbi Complete remission of refractory anemia following a single high dose of cyclophosphamide
    F Ferrara
    Division of Hematology, Cardarelli General Hospital, Naples, Italy
    Ann Hematol 78:87-8. 1999
  9. ncbi High-dose idarubicin and busulphan as conditioning for autologous stem cell transplantation in acute myeloid leukemia: a feasibility study
    F Ferrara
    Division of Hematology and Stem Cell Transplantation Unit, Cardarelli General Hospital, Naples, Italy
    Hematol J 2:214-9. 2001
  10. ncbi Continuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantation
    F Ferrara
    Division of Hematology and Stem Cell Transplantation Unit, A Cardarelli Hospital, Naples, Italy
    Bone Marrow Transplant 34:573-6. 2004

Collaborators

  • Lorella Melillo
  • B Pocali
  • L A Ferrara
  • F Morabito
  • M Montillo
  • G Specchia
  • A Venditti
  • C Guglielmi
  • A Pinto
  • P Fabris
  • A Celentano
  • L Pagano
  • M Margaglione
  • F Pane
  • L Amitrano
  • P R J Ames
  • Salvatore Palmieri
  • Giacomo Gianfaldoni
  • Sergio Amadori
  • Lucia Altucci
  • Robin Foa
  • Alessandra Tedeschi
  • Assunta Viola
  • Antonella Vitale
  • Antonio Cuneo
  • Marco Mancini
  • T Marotta
  • Daniela Laudati
  • Roberto Cairoli
  • Nicola Cascavilla
  • Cristina Mecucci
  • Francesco Fabbiano
  • Giuseppe Saglio
  • Giuseppe Cimino
  • Marco Vignetti
  • Agostino Tafuri
  • Maria Grazia Kropp
  • Laura Vicari
  • Angela Nebbioso
  • Mario Annunziata
  • F Pollio
  • S Viola
  • Pasqualino Correale
  • Claudio Falco
  • Francesco P Tambaro
  • Luciano Prossomariti
  • Lidia Larizza
  • Monia Lunghi
  • Rossella D'Elia
  • Anna Recchia
  • Antonio Romano
  • Giovanna Meloni
  • Giovanni Grillo
  • Giovanni Pizzolo
  • Anna Guarini
  • Mario Lazzarino
  • Laura Pezzetti
  • Enrica Morra
  • Carla Barbara Ripamonti
  • Cristina Ariola
  • Patrizia Colapietro
  • Michele Nichelatti
  • Claudio Fozza
  • Massimiliano Ammirabile
  • Francesca Elice
  • Patrizio Mazza
  • Mauro Krampera
  • Francesco Rodeghiero
  • Maria Rosaria D'Amico
  • Gianpaolo Nadali
  • Francesca Paoloni
  • Alessandro Beghini
  • Angel R de Lera
  • Emilie Voltz
  • Ettore M Schiavone
  • Loredana Elia
  • Pietro Leoni
  • Rosana Alvarez
  • Francesco Bresciani
  • Hinrich Gronemeyer
  • Emmanuelle Germain
  • Paola Bontempo
  • Valentina Derme
  • Concetta Ambrosino
  • Luciana Annino
  • Daniela Scappaticci
  • Filippo Marmont
  • Antonio Tabilio
  • Francesco Nobile
  • Alessandro Weisz

Detail Information

Publications38

  1. ncbi Therapeutic options and treatment results for patients over 75 years of age with acute myeloid leukemia
    F Ferrara
    Division of Hematology, Cardarelli Hospital, Naples, Italy
    Haematologica 83:126-31. 1998
    ..In a cohort of 70 consecutive AML patients aged over 75 years, we investigated the clinico-hematological characteristics and treatment results...
  2. ncbi CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy
    F Ferrara
    Divisione di Ematologia, Sezione TERE, Servizio di Immunoematologia, Ospedale Cardarelli, Naples, Italy
    J Clin Oncol 18:1295-300. 2000
    ..We investigated the prognostic relevance of CD56 in a series of patients with APL who were treated homogeneously with all-trans-retinoic acid (ATRA) and chemotherapy...
  3. ncbi Acute myeloid leukemia with t(8;21)/AML1/ETO: a distinct biological and clinical entity
    Felicetto Ferrara
    Divisione di Ematologia, Ospedale A Cardarelli, Naples, Italy
    Haematologica 87:306-19. 2002
    ..We focus on recent advances on biology and treatment of AML with t(8;21)...
  4. ncbi Therapy-related acute myeloid leukemia with t(9;11)(p12;q23) in a patient treated for acute promyelocytic leukemia
    Mario Annunziata
    Hematol J 4:289-91. 2003
  5. ncbi Vincristine as salvage treatment for refractory thrombotic thrombocytopenic purpura
    F Ferrara
    Division of Hematology, Cardarelli General Hospital, Naples, Italy
    Ann Hematol 78:521-3. 1999
    ..We conclude that vincristine is highly effective in the treatment of patients suffering from refractory TTP, with negligible toxicity...
  6. ncbi Complete remission in acute myeloid leukaemia with t(8;21) following treatment with G-CSF: flow cytometric analysis of in vivo and in vitro effects on cell maturation
    F Ferrara
    Division of Haematology, Cardarelli General Hospital, Napoli, Italy
    Br J Haematol 106:520-3. 1999
    ..Finally, in vitro studies demonstrated that G-CSF, as compared to other differentiation inducers, was able to induce a striking effect toward neutrophilic differentiation...
  7. ncbi Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of acute myeloid leukemia relapsing after autologous stem cell transplantation
    F Ferrara
    Divisione di Ematologia, Ospedale Cardarelli, Naples, Italy
    Ann Hematol 78:380-4. 1999
    ..We conclude that FLAG is effective in patients with AML who are relapsing after ASCT. The toxicity is acceptable, enabling most patients to receive further treatment, including second transplantation procedures...
  8. ncbi Complete remission of refractory anemia following a single high dose of cyclophosphamide
    F Ferrara
    Division of Hematology, Cardarelli General Hospital, Naples, Italy
    Ann Hematol 78:87-8. 1999
    ..In addition, it demonstrates that successful mobilization of peripheral blood stem cells can be induced with high-dose cyclo in MDS...
  9. ncbi High-dose idarubicin and busulphan as conditioning for autologous stem cell transplantation in acute myeloid leukemia: a feasibility study
    F Ferrara
    Division of Hematology and Stem Cell Transplantation Unit, Cardarelli General Hospital, Naples, Italy
    Hematol J 2:214-9. 2001
    ..We investigated the feasibility of a new conditioning regimen consisting of high dose IDA plus oral busulphan in patients undergoing autologous transplantation...
  10. ncbi Continuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantation
    F Ferrara
    Division of Hematology and Stem Cell Transplantation Unit, A Cardarelli Hospital, Naples, Italy
    Bone Marrow Transplant 34:573-6. 2004
    ..Our data demonstrate the feasibility of a conditioning regimen based on high-dose idarubicin plus busulfan in elderly AML patients. Results concerning reduction of relapse rate need confirmation in a larger series with longer follow-up...
  11. ncbi Aggressive salvage treatment is not appropriate for the majority of elderly patients with acute myeloid leukemia relapsed from first complete remission
    F Ferrara
    Divisione di Ematologia, Ospedale Cardarelli, Napoli, Italy
    Haematologica 86:814-20. 2001
    ....
  12. ncbi An antecedent diagnosis of refractory anemia with excess blasts has no prognostic relevance in acute myeloid leukemia of older adult patients
    S Palmieri
    Division of Hematology and Stem Cell Transplantation Unit, Cardarelli Hospital, Naples, Italy
    Ann Oncol 17:1146-51. 2006
    ..Conflicting results have been reported about the prognostic relevance of antecedent myelodysplastic syndrome (MDS) in acute myeloid leukemia (AML) of older adults...
  13. ncbi A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol)
    F Ferrara
    Division of Hematology, Cardarelli General Hospital, Naples, Italy
    Cancer 64:789-92. 1989
    ..Toxicity was mild and the relapse rate particularly low. It was concluded that the MiNa protocol represents an effective chemotherapy for advanced and/or progressive CLL...
  14. ncbi Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group. Gruppo Italiano Malattie Ematologiche Maligne Dell'Adulto
    M Montillo
    Divisione di Ematologia, Ospedale Niguarda Ca Granda, Milan, Italy
    Br J Haematol 111:334-7. 2000
    ..Psychosocial problems impaired treatment of some patients on an out-patient basis. Resistant disease, toxicity and logistic problems reduced the number of patients to whom this procedure could actually be applied...
  15. ncbi Recombinant interferon-alpha 2A as maintenance treatment for patients with advanced stage chronic lymphocytic leukemia responding to chemotherapy
    F Ferrara
    Division of Hematology, Cardarelli General Hospital, Naples, Italy
    Am J Hematol 41:45-9. 1992
    ..Toxicity was mild and patient compliance was excellent. We conclude that IFN alpha may have a role as maintenance therapy in CLL for patients responding to chemotherapy...
  16. ncbi Rituximab: a useful drug for a repeatedly relapsed hairy cell leukemia patient
    F Pollio
    Divisione di Ematologia, AORN A Cardarelli, Via Cardarelli 9, 80131 Naples, Italy
    Ann Hematol 81:736-8. 2002
    ..A fourfold reduction of leukemic cells was observed concomitantly with restoration of normal blood count and differential...
  17. ncbi Vincristine as treatment for recurrent episodes of thrombotic thrombocytopenic purpura
    F Ferrara
    Division of Hematology, Cardarelli Hospital, Via Niccoló Piccinni 6, 80128 Naples, Italy
    Ann Hematol 81:7-10. 2002
    ..We conclude that VCR is remarkably effective for recurrent thrombotic thrombocytopenic purpura with acceptable toxicity...
  18. ncbi Treating telangiectasias: my method
    F Ferrara
    Studio Flebologico Ferrara, Naples, Italy
    Minerva Cardioangiol 61:221-7. 2013
    ..2 mm are classified as type B, while isolated telangiectatic veins of ≤0.2 mm diameter are classed as type C. This histological and pathophysiological approach is the basis for the Authors' Multi-Therapy Treatment Protocol (MTT)...
  19. ncbi Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease
    L Amitrano
    Gastroenterology, A Cardarelli Hospital, Naples, Italy
    Am J Hematol 72:75-81. 2003
    ..Measurement of plasma HC and protein C in MPD may identify patients more likely to suffer arterial disease and splanchnic vein thrombosis and who may require plasma HC lowering in the former case...
  20. ncbi Cardiac structure and function and arterial circulation in hypertensive patients with and without metabolic syndrome
    L A Ferrara
    Department of Clinical and Experimental Medicine, Federico 2nd University of Naples, Naples, Italy
    J Hum Hypertens 21:729-35. 2007
    ..They show a deterioration in structure and function of the heart in comparison to hypertensive patients without MS, but no difference was detected in the carotid and peripheral arterial circulation...
  21. ncbi Recombinant interferon alpha-2b in the treatment of polycythemia vera
    R Cimino
    Division of Hematology, Cardarelli General Hospital, Naples, Italy
    Am J Hematol 44:155-7. 1993
    ..Treatment was well tolerated and side effects were easily controlled. We conclude that alpha-IFN may represent an attractive therapeutic option in the management of the proliferative stages of PV...
  22. ncbi Improvement of cardiovascular risk profile in an elderly population of low social level: the ICON (Improving Cardiovascular risk profile in Older Neapolitans) study
    T Marotta
    1Azienda Sanitaria Locale Napoli 1, Unità Operativa Assistenza Sanitaria di Base, Naples, Italy
    J Hum Hypertens 21:76-85. 2007
    ..Awareness of their health status was unsatisfactory. Treatment, specifically addressing patient-physician relationship, favourably affected cardiovascular risk profile...
  23. ncbi Complete remission induced by G-CSF in a patient with acute myeloid leukemia with t(8;21)(q22;q22)
    Felicetto Ferrara
    Division of Hematology, Cardarelli General Hospital, Via Niccoló Piccinni 6, Naples 80128, Italy
    Hematol J 4:218-21. 2003
    ..This case adds further evidence for a specific role of G-CSF in the treatment of AML with t(8;21), namely in patients who are not eligible for aggressive chemotherapy...
  24. ncbi High-dose cytarabine as consolidation treatment for patients with acute myeloid leukemia with t(8;21)
    Salvatore Palmieri
    Division of Hematology, Cardarelli Hospital, Naples, Italy
    Leuk Res 26:539-43. 2002
    ..Survival at 5 years is projected at 79%. Our data confirm the efficacy of repeated courses of HDARAC for patients with t(8;21) AML...
  25. ncbi An antecedent diagnosis of refractory anemia with excess blasts has no influence on mobilization of peripheral blood stem cells and hematopoietic recovery after autologous stem cell transplantation in acute myeloid leukemia
    Assunta Viola
    Division of Hematology and Stem Cell Transplantation Unit, Cardarelli Hospital, Naples, Italy
    Eur J Haematol 78:41-7. 2007
    ..Finally, neutrophil and platelet recovery after ASCT were comparable between the two groups. An antecedent diagnosis of RAEB has no impact on mobilization and collection of PBSCs in AML as well as on hematopoietic recovery after ASCT...
  26. ncbi Myeloablative chemotherapy followed by autologous stem cell infusion may overcome the adverse prognostic impact of FLT3 (foetal liver tyrosine kinase 3) mutations in patients with acute myeloid leukaemia and normal karyotype
    Salvatore Palmieri
    Division of Haematology and Stem Cell Transplantation Unit, Cardarelli Hospital, Naples, Italy
    Hematol Oncol 25:1-5. 2007
    ..However, it is to consider that autografted patients are highly selected for best response to induction, consolidation and mobilization, as well as for minor non-haematologic toxicity...
  27. ncbi Feasibility of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia
    Felicetto Ferrara
    Division of Haematology and Stem Cell Transplantation Unit, Cardarelli Hospital, Naples, Italy
    Leuk Lymphoma 47:1593-8. 2006
    ..It is concluded that APBSCT can result in an improvement of therapeutic results in AML of the elderly, but it is feasible in a minority of selected patients...
  28. ncbi HFE gene mutations in patients with acute leukemia
    Assunta Viola
    Divison of Hematology and Stem Cell Transplantion Unit, Cardarelli Hospital, Naples, Italy
    Leuk Lymphoma 47:2331-4. 2006
    ..02). In conclusion, our data demonstrate a correlation between the presence of the H63D mutation and the occurrence of ALL in adult patients...
  29. ncbi Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study
    Roberto Cairoli
    Division of Hematology, Ospedale Niguarda, Piazza Ospedale Maggiore 3, 20162 Milano, Italy
    Blood 107:3463-8. 2006
    ..126) and OS (P = .474) was observed between the c-KIT mutated other than TKD(816) (n = 7) and the c-KIT(-) patients. These findings indicate that c-KIT TKD(816) mutation has a negative impact on the outcome of AML with t(8;21)...
  30. ncbi Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol
    Antonella Vitale
    Department of Cellular Biotechnologies and Hematology, University La Sapienza Roma, Rome, Italy
    Blood 107:473-9. 2006
    ..An extensive biologic workup of adult T-ALL cases at presentation is recommended in order to design tailored therapeutic strategies aimed at improving CR rates...
  31. ncbi A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol
    Marco Mancini
    Department of Cellular Biotechnologies and Hematology, University La Sapienza Via Benevento 6 Rome, 00161 Italy
    Blood 105:3434-41. 2005
    ....
  32. ncbi High-dose idarubicin and busulphan as conditioning to autologous stem cell transplantation in adult patients with acute myeloid leukaemia
    Felicetto Ferrara
    Division of Haematology and Stem Cell Transplantation Unit, Cardarelli General Hospital, Naples, Italy
    Br J Haematol 128:234-41. 2005
    ..Our data show that a conditioning regimen based on high-dose IDA plus busulphan results in an encouraging reduction of the relapse rate after ASCT in AML...
  33. ncbi Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells
    Angela Nebbioso
    Dipartimento di Patologia Generale, Seconda Universita degli Studi di Napoli, Vico Luigi de Crecchio 7, 80138, Napoli, Italy
    Nat Med 11:77-84. 2005
    ..No apoptosis was seen in normal CD34(+) progenitor cells. Our results identify TRAIL as a mediator of the anticancer action of HDACIs...
  34. ncbi Prognostic factors and therapeutic options for relapsed or refractory acute myeloid leukemia
    Felicetto Ferrara
    Division of Hematology and Stem Cell Transplantation Unit, Cardarelli General Hospital, Naples, Italy
    Haematologica 89:998-1008. 2004
    ..The biological and clinical characteristics of relapsed AML are analyzed here...
  35. ncbi Unanswered questions in acute myeloid leukaemia
    Felicetto Ferrara
    Division of Haematology and Stem Cell Transplantation Unit, Cardarelli General Hospital, Naples, Italy
    Lancet Oncol 5:443-50. 2004
    ..Furthermore, some pivotal questions about the procedures of induction and postinduction therapy of AML remain unanswered, and substantial controversy exists on the optimum therapeutic approach for the disorder...
  36. ncbi Evaluation of leukemic contamination in peripheral blood stem cell leukaphereses vs bone marrow after consolidation therapy in acute myeloid leukemia: not a critical factor in outcome?
    Lorella Melillo
    Hematology and Stem Cell Unit, IRCCS Casa Sollievo della Sofferenza, S Giovanni Rotondo FG, Italy
    Haematologica 88:715-8. 2003
  37. ncbi De novo acute myeloid leukemia with multilineage dysplasia: treatment results and prognostic evaluation from a series of 44 patients treated with fludarabine, cytarabine and G-CSF (FLAG)
    Felicetto Ferrara
    Hematology Division, A O R N A Cardarelli, Naples, Italy
    Eur J Haematol 68:203-9. 2002
    ..To evaluate therapeutic results and prognostic factors from a series of 44 patients affected by de novo acute myeloid leukemia with multilineage dysplasia (MD-AML), treated with the combination of fludarabine, cytarabine and G-CSF (FLAG)...
  38. ncbi Autologous stem-cell transplantation for patients with acute myeloid leukemia aged over 60 yr
    Felicetto Ferrara
    Divisione di Ematologia, A O R N A Cardarelli, Via Niccoló Piccinni 6, 80126 Naples, Italy
    Eur J Haematol 69:200-4. 2002
    ..The objective of this study was to describe the disease characteristics and treatment results from a series of 22 elderly AML patients undergoing ASCT...